Stephan Gehring
Obere Zahlbacher Str. 63
Mainz, RP 55131, Germany
Mainz, RP 55131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Targeting and traceability of DY635-functionalized lipids for cholesterol-free, hepatocyte-directed lipid nanoparticles.
Journal: International journal of pharmaceutics
Published: March 18, 2026
Targeting and traceability of DY635-functionalized lipids for cholesterol-free, hepatocyte-directed lipid nanoparticles.
Journal: International journal of pharmaceutics
Published: March 18, 2026
Clinical spectrum and management outcomes of acute febrile illness Among children attending health facilities in northwestern Tanzania, 2020-2021.
Journal: Frontiers in pediatrics
Published: January 30, 2026
Novel Cu(II)-complex loaded Eudragit® nanoparticles: design, synthesis, characterization, and enhanced antitumor activity against triple-negative breast cancer.
Journal: International journal of pharmaceutics
Published: December 29, 2025
Staphylococcus aureus colonization and bloodstream infection in very preterm infants.
Journal: Gut microbes
Published: December 02, 2025
Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations.
Journal: International journal of biological macromolecules
Published: May 26, 2025
Insufficient immune protection in preterm infants due to delayed or incomplete hexavalent vaccination.
Journal: Frontiers in immunology
Published: May 09, 2025
Assessment of Prehospital Care for Pediatric Patients with Thermal Injuries: A Retrospective Study.
Journal: Journal of clinical medicine
Published: April 27, 2025
Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016-2022.
Journal: Malaria journal
Published: March 24, 2025
Non-malarial etiology of acute febrile episodes in children attending five healthcare facilities in Mwanza, Tanzania years 2020-2021.
Journal: Scientific reports
Published: February 23, 2025
CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial.
Journal: Nature communications
Published: February 02, 2025
mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 30, 2025
Last Updated: 09/26/2026